Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial.
Thilo ZanderThomas PabstSämi SchärStefan AebiUlrich MeyUrban NovakErika LerchGaëlle Rhyner AgocsJeroen GoedeZuzanna ManieckaStefanie HayozAxel RüferChristoph RennerChristoph DriessenPublished in: Leukemia (2023)